Apyx Medical Corp
APYXUS売上高
$53M
百万USD
営業利益
$-6M
百万USD
純利益
$-11M
百万USD
ROE
-77.1%
最新FY
EPS
-
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $9M | $-5M | - |
| FY2021 | Q2 | $11M | $-4M | $-0.12 |
| FY2021 | Q3 | $12M | $-4M | $-0.12 |
| FY2021 | FY | $49M | $-15M | $-0.44 |
| FY2022 | Q1 | $12M | $-6M | $-0.17 |
| FY2022 | Q2 | $10M | $-5M | $-0.16 |
| FY2022 | Q3 | $9M | $-6M | $-0.17 |
| FY2022 | FY | $45M | $-23M | $-0.67 |
| FY2023 | Q1 | $12M | $-3M | $-0.10 |
| FY2023 | Q2 | $14M | $-1M | $-0.03 |
| FY2023 | Q3 | $12M | $-5M | $-0.13 |
| FY2023 | FY | $52M | $-19M | $-0.54 |
| FY2024 | Q1 | $10M | $-8M | $-0.22 |
| FY2024 | Q2 | $12M | $-7M | $-0.19 |
| FY2024 | Q3 | $11M | $-5M | - |
| FY2024 | FY | $48M | $-23M | - |
| FY2025 | Q1 | $9M | $-4M | - |
| FY2025 | Q2 | $11M | $-4M | - |
| FY2025 | Q3 | $13M | $-2M | - |
| FY2025 | FY | $53M | $-11M | - |
| FY2026 | Q1 | $12M | $-2M | - |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $28M | $28M | $49M | $45M | $52M | $48M | $53M |
| 営業利益 | $-4M | $-5M | $-14M | $-21M | $-20M | $-14M | $-24M | $-17M | $-19M | $-6M |
| 純利益 | $-4M | $-5M | $-9M | $-20M | $-12M | $-15M | $-23M | $-19M | $-23M | $-11M |
| 総資産 | $35M | $31M | $96M | $85M | $74M | $69M | $52M | $79M | $65M | $67M |
| 純資産 | - | - | - | - | $64M | $54M | $38M | $27M | $14M | $15M |
| 自己資本 | $26M | $22M | $88M | $71M | $64M | $54M | $38M | $27M | $14M | $15M |
| 営業CF | $-3M | $-4M | $-21M | $-18M | $-16M | $-10M | $-20M | $-5M | $-18M | $-8M |
| EPS | $-0.15 | $-0.17 | $1.86 | $-0.58 | - | $-0.44 | $-0.67 | $-0.54 | - | - |
| BPS | $0.85 | $0.67 | $2.58 | $2.09 | $1.86 | $1.56 | $1.09 | $0.77 | $0.38 | $0.35 |
| ROE | -15.1% | -23.0% | -10.8% | -27.7% | -18.7% | -28.3% | -61.7% | -70.1% | -165.1% | -77.1% |